The glutamatergic pathways from the subthalamic nucleus to the basal ganglia output nuclei become overactivated and are thought to play key roles in the pathophysiology of the symptoms of PD because of the high density of GluN2B-containing NMDARs in the basal ganglia [146]. Here, GRIN2B is linked to Parkinson disease.